Estrogen-Responsive Ovarian Cancer Xenografts
The use of human tumor xenografts grown in immunodeficient animals as a model for human cancers is well established and their value depends on the extent to which their characteristics reflect the properties of a particular cancer in the clinical situation. For endocrine-sensitive tumors, the retention of hormone receptors in xenografts and their responsiveness to hormonal stimuli are essential criteria if they are to serve as appropriate models. Provided these criteria are met, such experimental systems allow detailed studies of the effects of hormones on hormone-sensitive tumor cells and the potential of endocrine therapies in an in vivo system (1 ).
- Analysis of HSV Oncolytic Virotherapy in Organotypic Cultures
- Angiogenesis Links Chronic Inflammation with Cancer
- Polymerase Chain Reaction Based Methods for Assessing Chimerism Following Allogeneic Bone Marrow Transplantation
- Induction of c-fos Gene Expression by Urokinase-Type Plasminogen Activator in Human Ovarian Cancer Cells
- Spontaneous and Experimental Metastasis Models: Nude Mice
- Use of Nucleotide Excision Repair-Deficient Mice as a Model For Chemically Induced Lung Cancer
- The Clinical Use of PET/CT in the Evaluation of Melanoma
- Metaphase Cytogenetic Techniques in Multiple Myeloma
- High-Throughput Technology: Green Fluorescent Protein to Monitor Cell Death
- HSV-tk/IL-2 Gene Therapy for Glioblastoma Multiforme